TRIAZOLAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triazolam, and when can generic versions of Triazolam launch?
Triazolam is a drug marketed by Hikma, Norvium Bioscience, Novast Labs, Sandoz, Watson Labs, and Zydus Pharms. and is included in six NDAs.
The generic ingredient in TRIAZOLAM is triazolam. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the triazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triazolam
A generic version of TRIAZOLAM was approved as triazolam by NOVAST LABS on October 20th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIAZOLAM?
- What are the global sales for TRIAZOLAM?
- What is Average Wholesale Price for TRIAZOLAM?
Summary for TRIAZOLAM
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Clinical Trials: | 19 |
| Patent Applications: | 4,079 |
| Drug Prices: | Drug price information for TRIAZOLAM |
| What excipients (inactive ingredients) are in TRIAZOLAM? | TRIAZOLAM excipients list |
| DailyMed Link: | TRIAZOLAM at DailyMed |
Recent Clinical Trials for TRIAZOLAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| RenJi Hospital | Phase 4 |
| University of Manitoba | N/A |
| Rocky Vista University, LLC | Phase 4 |
Pharmacology for TRIAZOLAM
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for TRIAZOLAM
Anatomical Therapeutic Chemical (ATC) Classes for TRIAZOLAM
US Patents and Regulatory Information for TRIAZOLAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | TRIAZOLAM | triazolam | TABLET;ORAL | 074224-001 | Jun 1, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | TRIAZOLAM | triazolam | TABLET;ORAL | 216890-001 | Nov 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Norvium Bioscience | TRIAZOLAM | triazolam | TABLET;ORAL | 074031-002 | Mar 25, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | TRIAZOLAM | triazolam | TABLET;ORAL | 213003-002 | Dec 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | TRIAZOLAM | triazolam | TABLET;ORAL | 216890-002 | Nov 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | TRIAZOLAM | triazolam | TABLET;ORAL | 074224-002 | Jun 1, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
